Impact of <i>KRAS</i> and <i>NRAS</i> mutations on outcomes in acute myeloid leukemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Impact of KRAS and NRAS mutations on outcomes in acute myeloid leukemia

Published:2023-04-12 Issue:5 Volume:64 Page:962-971
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Mustafa Ali Moaath K.¹²^ORCID,Williams Matthew T.³,Corley Elizabeth M.⁴,AlKaabba Fahad³,Niyongere Sandrine¹

Affiliation:

1. Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore, MD, USA

2. Leukemia Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA

3. Department of Medicine, School of Medicine, University of Maryland, Baltimore, MD, USA

4. Department of Medicine, Weil-Cornell Medical Center, New York, NY, USA

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2023.2190432

Reference16 articles.

1. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN

2. RAS mutation in acute myeloid leukemia is associated with distinct cytogenetic subgroups but does not influence outcome in patients younger than 60 years

3. KRAS overexpression independent of RAS mutations confers an adverse prognosis in cytogenetically normal acute myeloid leukemia

4. The prognosis and durable clearance of RAS mutations in patients with acute myeloid leukemia receiving induction chemotherapy

5. Prognostic importance of mutations in the ras proto-oncogenes in de novo acute myeloid leukemia

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel Mutations in Acute Erythroid Leukemia–A Case Report with Review of Literature;Indian Journal of Hematology and Blood Transfusion;2024-07-30

2. A 69 long noncoding RNA signature predicts relapse and acts as independent prognostic factor in pediatric AML;Blood Advances;2024-06-14

3. RAS mutations in myeloid malignancies: revisiting old questions with novel insights and therapeutic perspectives;Blood Cancer Journal;2024-04-24

4. Pathophysiology of Acute Myeloid Leukemia;Acta Haematologica;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3